Colombia on Alert for Measles Resurgence Amid Global Increase

Colombia is closely monitoring four suspected cases of measles, all linked to recent international travel, as the World Health Organization (WHO) reports a significant global resurgence of the disease. The Ministry of Health, under the leadership of Minister Guillermo Alfonso Jaramillo, is implementing measures to strengthen vaccination efforts and prevent outbreaks within the country.

Measles Cases and Global Trends

One of the initial four suspected cases has been ruled out by laboratory tests, while the remaining three are currently under analysis. This announcement comes as measles cases are rapidly increasing worldwide. According to the WHO, 247,623 cases were confirmed in 179 countries in 2023 , a dramatic increase compared to the 14,891 cases reported in the Americas in 2022. The potential for reintroduction of the disease to Colombia was previously highlighted by doctors and epidemiologists in anticipation of major global events, such as the upcoming Soccer World Cup.

Government Response and Vaccination Guidelines

In response to the escalating situation, the Colombian Ministry of Health has issued Circular 004 of 2026, outlining national guidelines to reinforce vaccination programs, enhance epidemiological surveillance, and prevent the importation of latest cases. The triple viral vaccine (measles, rubella, and mumps) and the bivalent SR vaccine remain freely available at over 3,000 vaccination points nationwide.

Strengthened controls are being implemented at airports, ports, and land crossings to identify individuals exhibiting symptoms consistent with measles – namely, fever and skin rash – to facilitate timely diagnosis and isolation of suspected cases. Healthcare facilities have activated care routes to prioritize patients presenting with fever and rash, requiring them to report any recent travel history within the past 21 days. Strict protocols are also being enforced to prevent intra-hospital transmission of the virus.

Who Should Be Vaccinated?

The Ministry of Health urges parents, caregivers, travelers, and healthcare personnel to verify and complete their vaccination schedules. Specific recommendations include:

• Infants aged 6-11 months: A “zero dose” is recommended for those traveling to host countries or residing in prioritized municipalities, with the complete schedule administered at 12 and 18 months.
• Children aged 1-10 years: Two doses of the triple viral vaccine are required.
• Individuals aged 6-16 years: An additional dose of the SR vaccine is recommended if they did not participate in the 2020-2021 campaign.
• Travelers aged 11-59 years: One dose is recommended at least 15 days before travel, provided they lack verifiable vaccination history.
• Healthcare workers: Facilities must verify vaccination status and administer additional doses as needed.
• Contacts of suspected cases under 60 years of age or with uncertain vaccination history: Vaccination is recommended.
• Individuals involved in tourism, hospitality, and international transportation: Vaccination is recommended.

Vaccine Safety and Effectiveness

Health organizations, including the World Health Organization, emphasize the safety and effectiveness of the measles vaccine. Vaccination has saved an estimated 94 million lives over the past 50 years, primarily among children. The vaccine is also a highly cost-effective public health intervention, with the cost of immunizing a child being less than one dollar. The widely debunked claim linking the measles vaccine to autism has been thoroughly discredited, with the original study retracted due to fraudulent data.

Like all vaccines, the measles vaccine can cause mild and temporary side effects, such as fever or redness at the injection site, but serious adverse events are extremely rare.